The genotoxicity study of resveratrol in primary gastric adenocarcinoma cell cultures

Romanian Journal of Morphology and Embryology

Volumn 50, Issue 3, 2008, Pages 429-433

  Mitrut P ^a   Burada, F L ^a   Enescu, Aurelia ^a   Scorei, R ^b   Badea, Daniela ^a   Genunche Dumitrescu, Amelia ^a   Rogoz, I ^a   Manea, Mǎdǎlina ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b UNIVERSITY OF CRAIOVA   (Romania)

Author keywords

Adenocarcinoma; Cell culture; Gastric cancer; Micronuclei; Resveratrol

Indexed keywords

RESVERATROL; STILBENE DERIVATIVE;

AGED; ARTICLE; GENETICS; HUMAN; MALE; MICRONUCLEUS TEST; MUTAGEN TESTING; PATHOLOGY; STOMACH TUMOR; TUMOR CELL CULTURE;

AGED; HUMANS; MALE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; STILBENES; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 70349191927     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LANGCAKE P., PRYCE R. J., The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury, Physiol Plant Pathol, 1976, 9(1):77-86.
2. LANGCAKE P., MCCARTHY W. V., The relationship of resveratrol production to infection of grapevine leaves by Botrytis cinerea, Vitis, 1979, 18(3):244-253.
3. BHAT K. P. L., KOSMEDER J. W. 2ND, PEZZUTO J. M., Biological effects of resveratrol, Antioxid Redox Signal, 2001, 3(6):1041-1064.
4. JANG M., CAI L., UDEANI G. O., SLOWING K. V., THOMAS C. F., BEECHER C. W. W., FONG H. H. S., FARNSWORTH N. R., KINGHORN A. D., MEHTA R. G., MOON R. C., PEZZUTO J. M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 1997, 275(5297):218-220.
5. SUBBARAMAIAH K., CHUNG W. J., MICHALUART P., TELANG N., TANABE T., INOUE H., JANG M., PEZZUTO J. M., DANNENBERG A. J., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells, J Biol Chem, 1998, 273(34):21875-21882.
6. SUBBARAMAIAH K., MICHALUART P., CHUNG W. J., TANABE T., TELANG N., DANNENBERG A. J., Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells, Ann NY Acad Sci, 1999, 889:214-223.
7. AGGARWAL B. B., BHARDWAJ A., AGGARWAL R. S., SEERAM N. P., SHISHODIA S., TAKADA Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res, 2004, 24(5A):2783-2840.
8. MAHADY G. B., PENDLAND S. L., CHADWICK L. R., Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro, Am J Gastroenterol, 2003, 98(6):1440-1441.
9. MAHADY G. B., PENDLAND S. L., Resveratrol inhibits the growth of Helicobacter pylori in vitro, Am J Gastroenterol, 2000, 95(7):1849.
10. SCHMITT E., LEHMANN L., METZLER M., STOPPER H., Hormonal and genotoxic activity of resveratrol, Toxicol Lett, 2002, 136(2):133-142.
11. MATSUOKA A., FURUTA A., OZAKI M., FUKUHARA K., MIYATA N., Resveratrol, a naturally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line, Mutat Res, 2001, 494(1-2):107-113.
12. HANEKE K. E., CARSON B. L., GREGORIO M. A., HARDY R., BELUE N. S., trans-Resveratrol [501-36-0]: review of toxicological literature, Research Triangle Park, NC: Integrated Laboratory Systems, March 2002, website http://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/resveratrol.pdf
13. ATTEN M. J, ATTAR B. M, MILSON T., HOLIAN O., Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism, Biochem Pharmacol, 2001, 62(10):1423-1432.
14. HOLIAN O., WAHID S., ATTEN M. J., ATTAR B. M., Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide, Am J Physiol Gastrointest Liver Physiol, 2002, 282(5):G809-816.
15. ZHOU H. B., YAN Y., SUN Y. N., ZHU J. R., Resveratrol induces apoptosis in human esophageal carcinoma cells, World J Gastroenterol, 2003, 9(3):408-411.
16. CHANG T. K. H., CHEN J., LEE W. B. K., Differential inhibition and inactivation of human CYP1 enzymes by trans- resveratrol: evidence for mechanisms-based inactivation of CYP1A2, J Pharmacol Exp Ther, 2001, 299(3):874-882.
17. GUSMAN J., MALONNE H., ATASSI G., A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol, Carcinogenesis, 2001, 22(8):1111-1117.
18. KUNDU J. K., SURH Y. J., Molecular basis of chemo-prevention by resveratrol: NF-kappaB and AP-1 as potential targets, Mutat Res, 2004, 555(1-2):65-80.
19. BODE A. M., DONG Z., Targeting signal transduction pathways by chemopreventive agents, Mutat Res, 2004, 555(1-2):33-51.
20. MAHYAR-ROEMER M., ROEMER K., p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents, Oncogene, 2001, 20(26):3387-3398.
21. PINTO M. C., GARCÍA-BARRADO J. A., MACÍAS P., Resveratrol is a potent inhibitor of the dioxygenase activity of lipoxygenase, J Agric Food Chem, 1994, 47(12):4842-4846.